2World Health Organization. WHO handbook for reporting results of cancer treatment, WHO Publication 48 Geneva, Switzerland[J]. World Health Organization, 1979,48(7): 14- 21.
3Sardi J E, Giaroli A, Sananes C, et al. Long-term follow up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results[J].Gynecol Oncol, 1997,67 (1): 61 - 69.
4Zanetta G, Lissoni A, Gabriele A, et al. Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinona[J]. Gynecol Oncol, 1997,64(3) :431-435.
5Whitney C W, Sause W, Bundy B N, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage Ⅱ B-ⅣA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study[J]. J Clin Oncol,1999,17(5): 1339-1348.
6Richmond R C. Toxic variability and radiation sensitization by dichlorodiammineplatinum (Ⅱ) complexes in Salmonella typhimurium cells[J]. Radiat Res, 1984, 99(3):596-608.
7Wallner K E, Li G C. Effect of cisplatin resistance on cellular radiation response[J]. Int J Radiat Oncol Biol Phy, 1987,13 (4):587-591.
8Rose P G, Bundy B N, Watkins E B,et al. Concurrent cisplatinbased radiotherapy and chemotherapy for locally advanced cervical cancer[J]. N EnglJ Med,1999,340(15):1144-1153.
9Peters W A, Lin P Y, Barrett R J, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of cervix[J]. J Clin Oncol, 2000,18(8):1606-1613.
10Green JA, Kirwan JM. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and metaanalysis[J]. Lancet. 2001,358(9284) :781.
